Sfoglia per Autore
INCIDENCE AND SEVERITY OF NONALCOHOLIC FATTY LIVER DISEASE ASSOCIATED WITH IMPAIRED LIPID AND GLUCOSE METABOLISM ARE PREDICTED BY SREBF POLYMORPHISM.
2012-01-01 R. Gambino; S. Bo; G. Musso; S. Pinach; N. Alemanno; M. Potenza; F. Saba; M. Cassader.
Anti-HSP70 levels and the metabolic syndrome: the Casale Monferrato Study
2012-01-01 Lorenzati B; Giunti S; Barutta F; PInach S; Cavallo Perin P; Bruno G; Gruden G
Associazione tra anti-HSP70 e sindrome plurimetabolica: il Casale Monferrato Study
2012-01-01 Lorenzati B; Giunti S; Barutta F; Pinach S; Amione C; Tricarico M; Landi A; Schimmenti A; Cavallo Perin P; Bruno G; Gruden G
Hippocampal heat shock protein 25 expression in streptozotocin-induced diabetic mice.
2012-01-01 Mastrocola R; Barutta F; Pinach S; Bruno G; Perin PC; Gruden G.
Urinary exosomal microRNA signature in incipient diabetic nephropathy
2012-01-01 Barutta F; Tricarico M; Corbelli A; Pinach S; Grimaldi S; Bruno G; Rastaldi M; Cavallo Perin P; Gruden G
NH2-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: The role of tumor necrosis factor-α
2012-01-01 Gruden G; Barutta F; Chaturvedi N; Schalkwijk C; Stehouwer CD; Pinach S; Manzo M; Loiacono M; Tricarico M; Mengozzi G; Witte DR; Fuller JH; Perin PC; Bruno G.
Effect of CB2 receptor deletion in streptozotocin-induced diabetic mice
2011-01-01 Barutta F; Corbelli A; Pinach S; Rastaldi MP; Cavallo Perin P; Gruden G
Protective role of cannabinoid receptor type-2 in a mouse model of diabetic nephropathy
2011-01-01 Barutta F; Piscitelli F; Pinach S; Bruno G; Gambino R; Rastaldi MP; Salvidio G; Di Marzo V; Cavallo Perin P; Gruden G
ATTIVAZIONE DEL RECETTORE CB2 E NEFROPATIA DIABETICA SPERIMENTALE
2010-01-01 Barutta F; Gambino R; Pinach S; Cavallo Perin P; Gruden G
Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy
2010-01-01 Barutta F; Corbelli A; Mastrocola R; Gambino R; Di Marzo V; Pinach S; Rastaldi MP; Perin PC; Gruden G.
Serum heat shock protein 27 is a new circulating biomarker for hepatocellular carcinoma
2009-01-01 Cosso L; Carucci P; Gruden G; Lolli V; Rolle E; Pinach S; Abate ML; Brunello F; Bruno G; Rizzetto M; Cavallo Perin P
Effects of CB1 Blockade In Experimental Diabetic Nephropathy
2009-01-01 Barutta F; Giunti S; Mastrocola R; Pinach S; Giardino L; Rastaldi MP; Cavallo Perin P; Gruden G.
Phytosterol-Enriched Yogurt Increases LDL Affinity and Reduces CD36 Expression in Polygenic Hypercholesterolemia
2009-01-01 Ruiu G; Pinach S; Veglia F; Gambino R; Marena S; Uberti B; Alemanno N; Burt D; Pagano G; Cassader M.
Effect of the MCP-1/CCR2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes
2009-01-01 Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Cavallo Perin P; Camussi G; Gruden G.
Anti-heat shock protein 27 antibody levels and diabetes complications in the EURODIAB study
2009-01-01 Burt D; Bruno G; Chaturvedi N; Schalkwijk C; Stehouwer CD; Witte DR; Fuller JH; Pinach S; Perin PC; Gruden G.
ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study
2009-01-01 Gruden G; Bruno G; Chaturvedi N; Burt D; Pinach S; Schalkwijk C; Stehouwer CD; Witte DR; Fuller JH; Cavallo Perin P
Espressione delle Heat Shock Proteins nella nefropatia diabetica sperimentale
2008-01-01 Pinach S; Barutta F; Forbes J; Chiarle R; Giunti S; Arnstein M; Miceli I; Cavallo Perin P; Camussi G; Cooper ME; Gruden G
Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells
2008-01-01 GIUNTI S; TESCH GH; PINACH S; BURT DJ; COOPER ME; CAVALLO-PERIN P; CAMUSSI G; GRUDEN G
Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy
2008-01-01 Gruden G; Bruno G; Chaturvedi N; Burt D; Schalkwijk C; Pinach S; Stehouwer CD; Witte DR; Fuller JH; Perin PC
Increased retinal HSP27 expression in early experimental diabetes
2008-01-01 Burt D; Pinach S; Berrone E; Miceli I; Porta M; Cavallo Perin P; Gruden G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| INCIDENCE AND SEVERITY OF NONALCOHOLIC FATTY LIVER DISEASE ASSOCIATED WITH IMPAIRED LIPID AND GLUCOSE METABOLISM ARE PREDICTED BY SREBF POLYMORPHISM. | 2012 | R. Gambino; S. Bo; G. Musso; S. Pinach; N. Alemanno; M. Potenza; F. Saba; M. Cassader. | |
| Anti-HSP70 levels and the metabolic syndrome: the Casale Monferrato Study | 2012 | Lorenzati B; Giunti S; Barutta F; PInach S; Cavallo Perin P; Bruno G; Gruden G | |
| Associazione tra anti-HSP70 e sindrome plurimetabolica: il Casale Monferrato Study | 2012 | Lorenzati B; Giunti S; Barutta F; Pinach S; Amione C; Tricarico M; Landi A; Schimmenti A; Cavallo Perin P; Bruno G; Gruden G | |
| Hippocampal heat shock protein 25 expression in streptozotocin-induced diabetic mice. | 2012 | Mastrocola R; Barutta F; Pinach S; Bruno G; Perin PC; Gruden G. | |
| Urinary exosomal microRNA signature in incipient diabetic nephropathy | 2012 | Barutta F; Tricarico M; Corbelli A; Pinach S; Grimaldi S; Bruno G; Rastaldi M; Cavallo Perin P; Gruden G | |
| NH2-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: The role of tumor necrosis factor-α | 2012 | Gruden G; Barutta F; Chaturvedi N; Schalkwijk C; Stehouwer CD; Pinach S; Manzo M; Loiacono M; Tricarico M; Mengozzi G; Witte DR; Fuller JH; Perin PC; Bruno G. | |
| Effect of CB2 receptor deletion in streptozotocin-induced diabetic mice | 2011 | Barutta F; Corbelli A; Pinach S; Rastaldi MP; Cavallo Perin P; Gruden G | |
| Protective role of cannabinoid receptor type-2 in a mouse model of diabetic nephropathy | 2011 | Barutta F; Piscitelli F; Pinach S; Bruno G; Gambino R; Rastaldi MP; Salvidio G; Di Marzo V; Cavallo Perin P; Gruden G | |
| ATTIVAZIONE DEL RECETTORE CB2 E NEFROPATIA DIABETICA SPERIMENTALE | 2010 | Barutta F; Gambino R; Pinach S; Cavallo Perin P; Gruden G | |
| Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy | 2010 | Barutta F; Corbelli A; Mastrocola R; Gambino R; Di Marzo V; Pinach S; Rastaldi MP; Perin PC; Gruden G. | |
| Serum heat shock protein 27 is a new circulating biomarker for hepatocellular carcinoma | 2009 | Cosso L; Carucci P; Gruden G; Lolli V; Rolle E; Pinach S; Abate ML; Brunello F; Bruno G; Rizzetto M; Cavallo Perin P | |
| Effects of CB1 Blockade In Experimental Diabetic Nephropathy | 2009 | Barutta F; Giunti S; Mastrocola R; Pinach S; Giardino L; Rastaldi MP; Cavallo Perin P; Gruden G. | |
| Phytosterol-Enriched Yogurt Increases LDL Affinity and Reduces CD36 Expression in Polygenic Hypercholesterolemia | 2009 | Ruiu G; Pinach S; Veglia F; Gambino R; Marena S; Uberti B; Alemanno N; Burt D; Pagano G; Cassader M. | |
| Effect of the MCP-1/CCR2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes | 2009 | Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Cavallo Perin P; Camussi G; Gruden G. | |
| Anti-heat shock protein 27 antibody levels and diabetes complications in the EURODIAB study | 2009 | Burt D; Bruno G; Chaturvedi N; Schalkwijk C; Stehouwer CD; Witte DR; Fuller JH; Pinach S; Perin PC; Gruden G. | |
| ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study | 2009 | Gruden G; Bruno G; Chaturvedi N; Burt D; Pinach S; Schalkwijk C; Stehouwer CD; Witte DR; Fuller JH; Cavallo Perin P | |
| Espressione delle Heat Shock Proteins nella nefropatia diabetica sperimentale | 2008 | Pinach S; Barutta F; Forbes J; Chiarle R; Giunti S; Arnstein M; Miceli I; Cavallo Perin P; Camussi G; Cooper ME; Gruden G | |
| Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells | 2008 | GIUNTI S; TESCH GH; PINACH S; BURT DJ; COOPER ME; CAVALLO-PERIN P; CAMUSSI G; GRUDEN G | |
| Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy | 2008 | Gruden G; Bruno G; Chaturvedi N; Burt D; Schalkwijk C; Pinach S; Stehouwer CD; Witte DR; Fuller JH; Perin PC | |
| Increased retinal HSP27 expression in early experimental diabetes | 2008 | Burt D; Pinach S; Berrone E; Miceli I; Porta M; Cavallo Perin P; Gruden G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile